Accuracy - Phase Advance

Beginning in 2014, we conducted in silico trials:

Millions of patients predictions.

Thousands of clinical response parameters per patient per day.

Different doses, different genetic backgrounds.

Following our predictions, doctors held clinical trials.

8 prospective clinical trials.

29,111 human patients.

Hundreds of daily response parameters per patient.

Our predictions of patient response parameters, per patient, per day were within 99.94% of those observed in the 29,111 patients.

Phase Advance is unique. We have been tested and found accurate, years post our predictions

Based on predictions made by PAAI in lung infections, metabolic syndrome, & liver disease in >29,000 patients
The weighted accuracy was 99.94% (95% credible intervals: 99.52-100%)

Let us know how we can help you.